SCHEMBL2493433

SCHEMBL2493433

[CH2]c1cccc(-c2ccccc2NC)c1-c1ccccc1NC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
EGFR P00533 1/20 0.46
PABPC1 P11940 1/20 0.46
MAPK1 P28482 1/20 0.46
PDK2 Q15119 1/20 0.38
USP2 O75604 3/20 0.36
POLB P06746 3/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
RECQL P46063 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ACHE P22303 3/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2495564 0.84 MAPT (0.42) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL2492175 0.80 MEN1 (0.47) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL8927888 0.78 MAPT (0.52) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL2488749 0.78 IDO1 (0.41) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL2489196 0.75 MEN1 (0.40) MAPTTDP1L3MBTL1SMN1; SMN2EGFR
SCHEMBL176875 0.74
SCHEMBL27376821 0.74 MAPK1 (0.38) MAPTL3MBTL1RAB9ASMN1; SMN2PABPC1
SCHEMBL21903975 0.71 MAPT (0.42) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL2492794 0.69 ALDH1A1 (0.43) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL2491927 0.69 TSHR (0.38) RAB9ASMN1; SMN2PDK2POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MAPT 3454/4885TDP1 2051/4885L3MBTL1 895/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MAPT 3294/4885TDP1 2151/4885L3MBTL1 644/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MAPT 3128/4885TDP1 2238/4885L3MBTL1 680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.